Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does difluoromethylornithine prevent recurrence in low-risk superficial bladder cancer?

Nature Clinical Practice Urology volume 4, pages 240–241 (2007)Cite this article

boxed-textMessing E et al. (2006) Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer. J Urol 176: 500–504

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Busby JE and Kamat AM (2005) Chemoprevention for bladder cancer. J Urol 176: 1914–1920

    Article  Google Scholar 

  2. Donat SM et al. (2004) Efficacy of office fulguration for recurrent low grade papillary bladder tumors. J Urol 171: 636–639

    Article  Google Scholar 

  3. Yossepowitch O et al. Risks and benefits of surveillance cystoscopy for recurrent bladder tumors. J Urol, in press

  4. Fleshner N et al. (1999) Influence of smoking status on disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer 86: 2192–2194

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Mandy Aujla, Assistant Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Urology, Memorial Sloan–Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA herrh@mskcc.org

Authors and Affiliations

  1. HW Herr is Director of Bladder Cancer Research, and a Urologic Surgeon specializing in bladder cancer, at Memorial Sloan–Kettering Cancer Center, and Professor of Urology at Cornell University Medical College, in New York, NY, USA.,

    Harry W Herr

Authors
  1. Harry W Herr
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herr, H. Does difluoromethylornithine prevent recurrence in low-risk superficial bladder cancer?. Nat Rev Urol 4, 240–241 (2007). https://doi.org/10.1038/ncpuro0753

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0753

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing